LNC
50
5
DVA
70
4
KMI
83
2
MTCH
40
14
TSCO
53
-5
MNST
68
3
DTE
40
6
JNPR
54
-2
HON
70
5
EQIX
62
-3
NOC
56
2
MCHP
41
-4
RL
78
-5
HCA
53
2
AON
60
-2
IRM
42
-4
KMB
28
-2
STX
55
-5
PX
79
6
KLAC
47
-3
LNC
50
5
DVA
70
4
KMI
83
2
MTCH
40
14
TSCO
53
-5
MNST
68
3
DTE
40
6
JNPR
54
-2
HON
70
5
EQIX
62
-3
NOC
56
2
MCHP
41
-4
RL
78
-5
HCA
53
2
AON
60
-2
IRM
42
-4
KMB
28
-2
STX
55
-5
PX
79
6
KLAC
47
-3
Financhill
Back

Caribou Biosciences Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Buy
67

CRBU
Caribou Biosciences

Last Price:
2.35
Seasonality Move:
-3.22%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Caribou Biosciences Price Quote

$2.35
-0.45 (-15.92%)
(Updated: November 12, 2024 at 5:55 PM ET)

Caribou Biosciences Key Stats

Buy
67
Caribou Biosciences (CRBU) is a Buy
Day range:
$2.55 - $2.85
52-week range:
$1.50 - $8.33
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.84
P/B ratio:
0.9%
Volume:
1.5M
Avg. volume:
1.3M
1-year change:
-27.4%
Market cap:
$253.1M
Revenue:
$34.5M
EPS:
$-1.66

How Much Does Caribou Biosciences Make?

Is Caribou Biosciences Growing As A Company?

  • What Is Caribou Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.91%
  • What Is Caribou Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Caribou Biosciences Stock Price Performance

What Is Caribou Biosciences 52-Week High & Low?

Caribou Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Caribou Biosciences?

Is Caribou Biosciences Cash Flow Positive?

  • What Is CRBU Cash Flow From Operations?
    Cash flow from operations (TTM) is -$124.1M
  • What Is Caribou Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $12.8M
  • What Is Caribou Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $39.2M

Caribou Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    CRBU return on invested capital is -43.52%
  • What Is Caribou Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -36.78%
  • What Is CRBU Return On Equity?
    ROE is a measure of profitability and is -43.52%

Caribou Biosciences Earnings Date & Stock Price

Caribou Biosciences Competitors

  • Who Are Caribou Biosciences's Competitors?
    Below is a list of companies who compete with Caribou Biosciences or are related in some way:
    • Arbutus Biopharma Corp (ABUS)
    • Biomarin Pharmaceutical Inc (BMRN)
    • Lexicon Pharmaceuticals Inc (LXRX)
    • Precigen Inc (PGEN)
    • Vir Biotechnology Inc (VIR)

Caribou Biosciences Dividend Yield

Caribou Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 15.1%
Revenue: -91.45% -34.66%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 15.50
Upside from Last Price: 454.56%

Major Shareholders

  • How many CRBU shares are owned by institutional investors?
    75.4M CRBU shares are owned by institutional investors
  • How many CRBU shares are owned by insiders?
    1.2M CRBU shares are owned by insiders